18 May 2021
Next-generation TAVR device will enable lifetime management of aortic stenosis patients
Sponsored by Anteris Technologies
Speaker:
M. Reardon
Summary
Watch this session presented by Michael Reardon in order to learn more about supra-annular leaflet functioning in a balloon expandable TAVR device that enables commissural alignment, about 3D single-piece aortic valve design and how it contributes to improved TAVR durability, about the ADAPT tissue science and its proven resistance to calcification for over 10 years, and eventually about the DurAVR early feasibility trial.
Learning Objectives
- To learn more about supra-annular leaflet functioning in a balloon expandable TAVR device that enables commissural alignment
- To learn more about 3D single-piece aortic valve design and how it contributes to improved TAVR durability
- To learn more about the ADAPT tissue science and its proven resistance to calcification for over 10 years
- To learn more about the DurAVR early feasibility trial
